Walmsley S - Search Results

1

Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients.

Antoniou T, Szadkowski L, Walmsley S, Cooper C, Burchell AN, Bayoumi AM, Montaner JS, Loutfy M, Klein MB, Machouf N, Tsoukas C, Wong A, Hogg RS, Raboud J; Canadian Observational Cohort (CANOC) collaboration. Antoniou T, et al. Among authors: walmsley s. BMC Infect Dis. 2017 Apr 11;17(1):266. doi: 10.1186/s12879-017-2379-8. BMC Infect Dis. 2017. PMID: 28399819 Free PMC article.

2

CD36 deficiency induced by antiretroviral therapy.

Serghides L, Nathoo S, Walmsley S, Kain KC. Serghides L, et al. Among authors: walmsley s. AIDS. 2002 Feb 15;16(3):353-8. doi: 10.1097/00002030-200202150-00006. AIDS. 2002. PMID: 11834946 Clinical Trial.

3

Can structured treatment interruptions (STIs) be used as a strategy to decrease total drug requirements and toxicity in HIV infection?

Walmsley S, Loutfy M. Walmsley S, et al. J Int Assoc Physicians AIDS Care (Chic). 2002 Summer;1(3):95-103. doi: 10.1177/154510970200100304. J Int Assoc Physicians AIDS Care (Chic). 2002. PMID: 12942682 Review.

4

Clinical impact of double protease inhibitor boosting with lopinavir/ritonavir and amprenavir as part of salvage antiretroviral therapy.

Loutfy M, Raboud J, Thompson C, Tseng A, Abdurrahman Z, Kovacs C, Rachlis A, Phillips E, Rubin G, Gough K, Walmsley S. Loutfy M, et al. Among authors: walmsley s. HIV Clin Trials. 2003 Sep-Oct;4(5):301-10. doi: 10.1310/7LYW-GQFF-WPRQ-K3QW. HIV Clin Trials. 2003. PMID: 14583846

5

Rosiglitazone for HIV-1 lipoatrophy.

Cavalcanti RB, Raboud J, Kain KC, Walmsley S. Cavalcanti RB, et al. Among authors: walmsley s. Lancet. 2004 May 29;363(9423):1828-9; author reply 1829. doi: 10.1016/S0140-6736(04)16318-6. Lancet. 2004. PMID: 15172791 No abstract available.

6

Reproducibility of DXA estimations of body fat in HIV lipodystrophy: implications for clinical research.

Cavalcanti RB, Cheung AM, Raboud J, Walmsley S. Cavalcanti RB, et al. Among authors: walmsley s. J Clin Densitom. 2005 Fall;8(3):293-7. doi: 10.1385/jcd:8:3:293. J Clin Densitom. 2005. PMID: 16055959

7

Mild to moderate symptoms do not correlate with lactate levels in HIV-positive patients on nucleoside reverse transcriptase inhibitors.

Tan D, Walmsley S, Shen S, Raboud J. Tan D, et al. Among authors: walmsley s. HIV Clin Trials. 2006 May-Jun;7(3):107-15. doi: 10.1310/95VE-A6KJ-WRQ0-1F8Y. HIV Clin Trials. 2006. PMID: 16880167 Clinical Trial.

8

A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy.

Cavalcanti RB, Raboud J, Shen S, Kain KC, Cheung A, Walmsley S. Cavalcanti RB, et al. Among authors: walmsley s. J Infect Dis. 2007 Jun 15;195(12):1754-61. doi: 10.1086/518005. Epub 2007 May 2. J Infect Dis. 2007. PMID: 17492590 Clinical Trial.

9

Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study.

Prior J, Burdge D, Maan E, Milner R, Hankins C, Klein M, Walmsley S. Prior J, et al. Among authors: walmsley s. Osteoporos Int. 2007 Oct;18(10):1345-53. doi: 10.1007/s00198-007-0428-7. Epub 2007 Jul 31. Osteoporos Int. 2007. PMID: 17665239

10

An estimate of the proportion of symptoms reported in self-administered questionnaires that are captured as adverse drug events in an observational database.

Raboud J, Lesosky M, Sterling S, Phillips E, Walmsley S, Bayoumi A. Raboud J, et al. Among authors: walmsley s. HIV Clin Trials. 2007 Sep-Oct;8(5):311-9. doi: 10.1310/hct0805-311. HIV Clin Trials. 2007. PMID: 17956832 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

623 results

Search Page

Filters